Differential Modulation of Angiogenesis by Erythropoiesis-Stimulating Agents in a Mouse Model of Ischaemic Retinopathy
Carmel M. McVicar, Liza M. Colhoun, Jodie L. Abrahams et al. · 2010
Read Differential Modulation of Angiogenesis by Erythropoiesis-Stimulating Agents in a Mouse Model of Ischaemic Retinopathy by Carmel M. McVicar, Liza M. Colhoun, Jodie L. Abrahams et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011870.txt.
Description
Carmel McVicar and colleagues compared anemia drugs in 2010 for an unwanted side effect: new blood vessel growth in the eye. The drugs, called erythropoiesis-stimulating agents, boost red blood cell production and are widely used for anemia. Doctors have worried they might also worsen vessel overgrowth in an oxygen-starved retina.
Using a mouse model of ischemic retinopathy, where the retina lacks oxygen, the team tested three agents side by side. The agents did not behave alike in their effect on vessel growth. Such differences matter when choosing an anemia drug for patients who already have fragile eye vessels, since the wrong pick could add harm where sight is at stake.
Catalog record
| CREATOR | Carmel M. McVicar, Liza M. Colhoun, Jodie L. Abrahams et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011870